Drug:
Reaction: PRODUCT USE ISSUE
20250101 - 20251231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 25059895 |
US |
||
Product use issue, |
||||
VARENICLINE, |
||||
| 702 | 25060747 |
US |
74 | 2 |
Expired product administered, Product use issue, Intentional product misuse, |
||||
| 703 | 25060800 |
CN |
75 | 1 |
Arrhythmia, Immune-mediated adverse reaction, Product use issue, |
||||
PEMBROLIZUMAB, CARBOPLATIN, PACLITAXEL, |
||||
| 704 | 25060817 |
US |
45 | 1 |
Anxiety, Product use issue, |
||||
FREMANEZUMAB-VFRM, FREMANEZUMAB-VFRM, |
||||
| 705 | 25060825 |
US |
73 | 2 |
Pruritus, Product use issue, Urticaria, |
||||
PEMBROLIZUMAB, LEVOTHYROXINE, |
||||
| 706 | 25060995 |
US |
2 | |
Product use issue, |
||||
ERTAPENEM, ERTAPENEM SODIUM, |
||||
| 707 | 25061144 |
US |
63 | 1 |
Adverse event, Product use issue, |
||||
LENALIDOMIDE, ALBUTEROL SULFATE, INSULIN ASPART, NITROGLYCERIN, ONDANSETRON HYDROCHLORIDE, LEVETIRACETAM, NABUMETONE, SPIRONOLACTONE, DICLOFENAC, DICLOFENAC SODIUM, FLUDROCORTISONE ACETATE, ACYCLOVIR, FUROSEMIDE, SIMVASTATIN, GABAPENTIN, FLUOXETINE HYDROCHLORIDE, DIVALPROEX SODIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, TOPIRAMATE, TOPIRAMATE SPINKLE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, TRIHEXYPHENIDYL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, LACTULOSE, CLOPIDOGREL, MORPHINE SULFATE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, ROPINIROLE HYDROCHLORIDE, PREDNISONE, |
||||
| 708 | 25061202 |
US |
||
Product use issue, Wrong technique in product usage process, |
||||
FLUTICASONE PROPIONATE, |
||||
| 709 | 25055644 |
US |
1 | |
Product use issue, Product dose omission issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 710 | 25055728 |
US |
2 | |
Therapy interrupted, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 711 | 25055814 |
US |
1 | |
Product use issue, Product dose omission issue, |
||||
PIMAVANSERIN TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TICAGRELOR, ESCITALOPRAM OXALATE, ESCITALOPRAM, RIVASTIGMINE, ERGOCALCIFEROL, |
||||
| 712 | 25055890 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 713 | 25055896 |
US |
1 | |
Product use issue, Product distribution issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 714 | 25055898 |
US |
1 | |
Inability to afford medication, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 715 | 25055964 |
US |
40 | 2 |
Myalgia, Oral pain, Fatigue, Brain fog, Arthralgia, Nausea, Product use issue, |
||||
PEMBROLIZUMAB, LENVATINIB, |
||||
| 716 | 25056029 |
US |
36 | 2 |
Dyspnoea, Product use issue, |
||||
ALBUTEROL SULFATE, ATOVAQUONE, BACLOFEN, EPINEPHRINE, ADRENALINUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE, RIZATRIPTAN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TOBRAMYCIN, URSODIOL, URSOSIOL, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VORICONAZOLE, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 717 | 25056052 |
US |
52 | |
Depression, Product use issue, |
||||
DEUTETRABENAZINE, |
||||
| 718 | 25054739 |
US |
2 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 719 | 25054822 |
US |
2 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 720 | 25054848 |
US |
50 | 2 |
Nausea, Product use issue, |
||||
BREMELANOTIDE, |
||||
| 721 | 25054872 |
US |
||
Product use issue, |
||||
AMBRISENTAN, |
||||
| 722 | 25055127 |
US |
1 | |
Product use issue, Product distribution issue, Product dose omission issue, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, CARBIDOPA AND LEVODOPA, |
||||
| 723 | 25055376 |
US |
||
Injection site haemorrhage, Injection site injury, Injection site pain, Product use issue, Device delivery system issue, Incorrect dose administered by device, Drug dose omission by device, |
||||
EXENATIDE, |
||||
| 724 | 25055433 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 725 | 25055519 |
CA |
40 | 2 |
Asthenia, Fibromyalgia, Blepharospasm, Blister, Breast cancer stage III, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Abdominal pain upper, Drug ineffective, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Infusion related reaction, Nausea, Off label use, Onychomadesis, Pain, Pemphigus, Pericarditis, Product use in unapproved indication, Product use issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Vomiting, Wound, Helicobacter infection, Hypercholesterolaemia, |
||||
ADALIMUMAB, BOTULINUM TOXIN TYPE A, LEVOMILNACIPRAN, NAPROXEN, NAPROXEN SODIUM, DESOGESTREL AND ETHINYL ESTRADIOL, |
||||
| 726 | 25058290 |
1 | ||
Product use issue, |
||||
ETANERCEPT, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, ETANERCEPT, PREDNISOLONE ACETATE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 727 | 25048304 |
US |
2 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 728 | 25048312 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 729 | 25048359 |
US |
78 | 1 |
Myocardial infarction, Pain, Fatigue, Rib fracture, Product use issue, |
||||
ENZALUTAMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DEGARELIX, FUROSEMIDE, GABAPENTIN, MIDODRINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PROCHLORPERAZINE, SEVELAMER CARBONATE, |
||||
| 730 | 25048476 |
US |
||
Abnormal withdrawal bleeding, Product use issue, |
||||
| 731 | 25048486 |
US |
||
No adverse event, Product use issue, Wrong technique in product usage process, |
||||
PRUCALOPRIDE, |
||||
| 732 | 25048488 |
US |
1 | |
Product use issue, Product distribution issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 733 | 25048642 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 734 | 25048826 |
US |
||
Condition aggravated, Drug ineffective for unapproved indication, Product use issue, |
||||
KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, |
||||
| 735 | 25048952 |
US |
83 | 1 |
Product use issue, Product distribution issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 736 | 25048962 |
US |
||
Suicidal ideation, Abortion spontaneous, Drug dependence, Female reproductive tract disorder, Menopause, Serum serotonin decreased, Menstruation irregular, Insomnia, Memory impairment, Compulsive sexual behaviour, Anxiety, Cerebral disorder, Anger, Menstrual clots, Product use issue, Product dose omission issue, Off label use, Product use in unapproved indication, |
||||
QUETIAPINE, QUETIAPINE, QUETIAPINE, ALPRAZOLAM, ALPRAZOLAM, ALPRAZOLAM, |
||||
| 737 | 25049092 |
US |
60 | 2 |
Pneumonia, Influenza, Rhinovirus infection, Product use issue, Product dose omission issue, Illness, Haemoglobin abnormal, Constipation, |
||||
IXAZOMIB, IXAZOMIB, AMOXICILLIN AND CLAVULANATE POTASSIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, LISINOPRIL, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, |
||||
| 738 | 25049125 |
US |
34 | 1 |
Schizophrenia, Product use issue, |
||||
DEUTETRABENAZINE, |
||||
| 739 | 25049184 |
US |
33 | 1 |
Connective tissue disorder, Condition aggravated, Off label use, Product use issue, Intentional product misuse, General physical health deterioration, |
||||
ANAKINRA, ANAKINRA, |
||||
| 740 | 25049257 |
US |
65 | 2 |
Off label use, Product use issue, |
||||
TUCATINIB, TUCATINIB, |
||||
| 741 | 25049454 |
US |
80 | 2 |
Throat irritation, Retching, Product use issue, Product use complaint, Intentional product misuse, Product taste abnormal, |
||||
APIXABAN, METOPROLOL TARTRATE, METOPROLOL, LEVOTHYROXINE SODIUM, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, OSIMERTINIB, |
||||
| 742 | 25049517 |
US |
||
Gastrooesophageal reflux disease, Product use issue, Product storage error, |
||||
ESOMEPRAZOLE MAGNESIUM, |
||||
| 743 | 25049530 |
US |
1 | |
Pain, Product use issue, |
||||
ADALIMUMAB-ADAZ, |
||||
| 744 | 25049587 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 745 | 25049651 |
US |
53 | 1 |
Injection site pain, Device issue, Incorrect dose administered, Product use issue, |
||||
ADALIMUMAB-BWWD, |
||||
| 746 | 25049857 |
US |
48 | 1 |
Dizziness, Product use issue, |
||||
DEUTETRABENAZINE, |
||||
| 747 | 25050002 |
US |
||
Drug dependence, Wrong technique in product usage process, Product use issue, |
||||
| 748 | 25050007 |
US |
20 | 2 |
No adverse event, Product availability issue, Product use issue, |
||||
LISDEXAMFETAMINE DIMESYLATE, |
||||
| 749 | 25050030 |
CA |
40 | 2 |
Abdominal discomfort, Ankle fracture, Blood pressure increased, Dizziness, Fall, Heart rate increased, Illness, Inappropriate schedule of product administration, Laryngitis, Malaise, Nasopharyngitis, Nausea, Paraesthesia, Product use issue, Pruritus, Road traffic accident, Skin irritation, Skin sensitisation, Speech disorder, Urticaria, Urticaria, Weight increased, Off label use, Wrong technique in product usage process, Therapeutic product effect decreased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CYCLOSPORINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, RANITIDINE, |
||||
| 750 | 25050038 |
US |
2 | |
Wrong technique in product usage process, Product use issue, |
||||
DICLOFENAC SODIUM, |
||||
| 751 | 25050289 |
CA |
||
Liver function test increased, Memory impairment, Peripheral swelling, Wound, Mobility decreased, Pemphigus, Psoriatic arthropathy, Spondylitis, Liver injury, Blood cholesterol increased, Seronegative arthritis, Rheumatoid factor positive, Sleep disorder, Swollen joint count increased, Asthenia, Musculoskeletal stiffness, Muscular weakness, Rheumatic fever, Rheumatoid arthritis, Rash, Swelling, Synovitis, Type 2 diabetes mellitus, Pain, Oedema, Pain in extremity, Nausea, Pericarditis, Vomiting, Weight decreased, Wound infection, Systemic lupus erythematosus, Hypertension, Wheezing, Prescribed overdose, Treatment failure, Drug ineffective, Therapeutic product effect decreased, Exposure during pregnancy, Maternal exposure during pregnancy, Product use issue, Off label use, Product use in unapproved indication, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, USTEKINUMAB, USTEKINUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB-ADAZ, SECUKINUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, APREMILAST, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, TOFACITINIB, TOFACITINIB, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, OXYCODONE, INFLIXIMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ACETAMINOPHEN AND CODEINE, SECUKINUMAB, RISEDRONATE SODIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, RAMIPRIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, MAGNESIUM, LISINOPRIL, LISINOPRIL, SULFASALAZINE, NAPROXEN, NAPROXEN SODIUM, ERYTHROMYCIN, AZATHIOPRINE, |
||||
| 752 | 25050298 |
CA |
58 | 2 |
Bursitis, Asthma, Psoriasis, Food allergy, Retching, Fluid retention, Hepatic enzyme increased, Exposure during pregnancy, Pyrexia, Headache, Foetal death, Overdose, Cardiac failure, Infection, Temperature regulation disorder, Constipation, Drug ineffective, Joint swelling, Back pain, Prescribed overdose, Upper respiratory tract infection, Erythema, Hyponatraemia, Drug intolerance, Rash, Immunodeficiency, Hypertension, Pain, Decreased immune responsiveness, Drug hypersensitivity, Off label use, Product use issue, Hyperhidrosis, Infusion related reaction, Coeliac disease, Fatigue, Thrombocytopenia, Rheumatoid arthritis, Rash erythematous, Nausea, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, MEPERIDINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DOLUTEGRAVIR SODIUM, ETANERCEPT, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALBUTEROL SULFATE, ALBUTEROL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, TOCILIZUMAB, FLUTICASONE PROPIONATE, PROGESTERONE, BUPROPION HYDROCHLORIDE, CLONIDINE, |
||||
| 753 | 25050621 |
US |
1 | |
Product use issue, |
||||
TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, |
||||
| 754 | 25050748 |
US |
78 | 2 |
Product use issue, |
||||
| 755 | 25050962 |
US |
2 | |
Thyroid disorder, Product use issue, |
||||
PEMBROLIZUMAB, MESALAMINE, HYDROCHLOROTHIAZIDE, EXEMESTANE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 756 | 25050973 |
US |
1 | |
Anxiety, Product use issue, |
||||
TREPROSTINIL, TREPROSTINIL, TAMSULOSIN HYDROCHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, EMPAGLIFLOZIN, LORAZEPAM, MAGNESIUM OXIDE, KETAMINE HYDROCHLORIDE, FINASTERIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, HEMORRHOIDAL, MINERAL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE, GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM, MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL, COCOA BUTTER, PHENYLEPHRINE HCL, PAIN RELIEF, MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI, HARD FAT, PHENYLEPHRINE HCL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MACITENTAN, CLONIDINE, KETOPROFEN, PREDNISONE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, DIGOXIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, GABAPENTIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 757 | 25051070 |
BR |
67 | 1 |
Immunodeficiency, Paraesthesia, Spinal cord neoplasm, Mobility decreased, Platelet count decreased, Malocclusion, Hypoaesthesia, Cerebral disorder, Dizziness, Headache, Red blood cell count decreased, Visual impairment, Spinal pain, Gait disturbance, Pain, Pain in extremity, Product use issue, |
||||
REGORAFENIB, METHADONE, METHADONE, METHADONE, METHADONE, |
||||
| 758 | 25051082 |
US |
80 | 2 |
Rash, Product use issue, |
||||
DEUTETRABENAZINE, ATENOLOL, MEMANTINE, MEMANTINE HYDROCHLORIDE, DIVALPROEX SODIUM, VITAMIN C, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, MIRTAZAPINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 759 | 25051187 |
US |
34 | 2 |
Product use issue, Product adhesion issue, |
||||
ESTRADIOL, |
||||
| 760 | 25051231 |
US |
73 | |
Dizziness, Dysstasia, Product use issue, |
||||
LORATADINE, LORATADINE, ZOLPIDEM TARTRATE, |
||||
| 761 | 25051424 |
US |
81 | 1 |
Product use issue, |
||||
APIXABAN, |
||||
| 762 | 25051425 |
US |
63 | 2 |
Product use issue, General physical health deterioration, |
||||
ABATACEPT, ABATACEPT, |
||||
| 763 | 25051463 |
JP |
||
Death, Hospitalisation, Product use issue, Drug ineffective for unapproved indication, |
||||
DESMOPRESSIN ACETATE, |
||||
| 764 | 25051635 |
CO |
2 | |
Oedema due to hepatic disease, General physical health deterioration, Memory impairment, Product use issue, |
||||
RIBOCICLIB, RIBOCICLIB, LETROZOLE, |
||||
| 765 | 25051859 |
BE |
2 | |
Ataxia, Somnolence, Vertigo, Product use issue, Intentional self-injury, Intentional overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 766 | 25051873 |
US |
||
Oxygen saturation decreased, Complication associated with device, Product use in unapproved indication, Product use issue, |
||||
NITRIC OXIDE, |
||||
| 767 | 25051885 |
US |
2 | |
Product use issue, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 768 | 25051923 |
US |
||
Hypotension, Complication associated with device, Product use issue, |
||||
NITRIC OXIDE, |
||||
| 769 | 25052177 |
US |
72 | 1 |
Malaise, Product prescribing error, Off label use, Product use issue, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 770 | 25052501 |
US |
||
Dry skin, Skin irritation, Product use issue, |
||||
ADAPALENE, |
||||
| 771 | 25052562 |
US |
11 | 1 |
Blood triglycerides increased, Product use issue, Product dose omission issue, |
||||
GIVINOSTAT, ERGOCALCIFEROL, LISINOPRIL, SPIRONOLACTONE, DEFLAZACORT, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROCORTISONE SODIUM SUCCINATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 772 | 25053840 |
US |
64 | 1 |
Product use issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 773 | 25054028 |
US |
4 | 1 |
Product use issue, |
||||
DUPILUMAB, |
||||
| 774 | 25054439 |
US |
28 | 2 |
Herpes virus infection, Condition aggravated, Product use issue, |
||||
DUPILUMAB, |
||||
| 775 | 25059056 |
|||
Drug ineffective, Product use issue, Therapy interrupted, |
||||
| 776 | 25043498 |
US |
50 | 2 |
Product use issue, |
||||
DASATINIB, FEXOFENADINE HYDROCHLORIDE, |
||||
| 777 | 25043529 |
BE |
||
Ataxia, Somnolence, Vertigo, Intentional overdose, Product use issue, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 778 | 25043591 |
US |
0 | 1 |
Epilepsy, Condition aggravated, Anger, Seizure, Insomnia, Irritability, Product use issue, Mental status changes, Drug ineffective, |
||||
VIGABATRIN, VIGABATRIN, VIGABATRIN, PREDNISONE, PREDNISONE, PREDNISONE, CLONIDINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), POLYETHYLENE GLYCOL 3350, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, GABAPENTIN, |
||||
| 779 | 25043601 |
US |
76 | 1 |
Dry mouth, Product use issue, |
||||
DEUTETRABENAZINE, LORAZEPAM, ARIPIPRAZOLE, GABAPENTIN, TAMSULOSIN HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 780 | 25043833 |
US |
1 | |
Liver disorder, Product use issue, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TREPROSTINIL, TREPROSTINIL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ROSUVASTATIN CALCIUM, TAMSULOSIN HYDROCHLORIDE, ALBUTEROL SULFATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LOSARTAN POTASSIUM, LOSARTAN, SACUBITRIL AND VALSARTAN, APIXABAN, SILDENAFIL CITRATE, SILDENAFIL, MACITENTAN, DAPAGLIFLOZIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SPIRONOLACTONE, OXYGEN, 0XYGEN, AMIODARONE HYDROCHLORIDE, AMLODIPINE BESYLATE, FUROSEMIDE, PRIMIDONE, DAPAGLIFLOZIN, DRONEDARONE, FLUTICASONE PROPIONATE AND SALMETEROL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 781 | 25043920 |
US |
77 | 2 |
Illness, Food poisoning, Product use issue, |
||||
MAVACAMTEN, |
||||
| 782 | 25043935 |
US |
46 | 1 |
Nausea, Vomiting, Catheter site bruise, Product use issue, Infusion site pain, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ALLOPURINOL, RIOCIGUAT, MACITENTAN, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, COLCHICINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, IVERMECTIN, OXYGEN, 0XYGEN, SPIRONOLACTONE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, KETAMINE HYDROCHLORIDE, CLONIDINE, KETOPROFEN, AMITRIPTYLINE HYDROCHLORIDE, GABAPENTIN, |
||||
| 783 | 25043972 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 784 | 25044193 |
US |
2 | |
Drug dependence, Product use issue, Therapy partial responder, Product dose omission issue, Drug ineffective, |
||||
GABAPENTIN, GABAPENTIN, DULOXETINE HYDROCHLORIDE, |
||||
| 785 | 25044303 |
US |
59 | 2 |
Product use issue, |
||||
MAVACAMTEN, |
||||
| 786 | 25044432 |
US |
2 | |
Application site pruritus, Application site irritation, Intentional product misuse, Product use issue, |
||||
| 787 | 25044767 |
US |
54 | 1 |
Product use issue, Illness, |
||||
LENALIDOMIDE, |
||||
| 788 | 25044788 |
US |
54 | 2 |
Off label use, Product use issue, |
||||
TUCATINIB, CAPECITABINE, |
||||
| 789 | 25044949 |
JP |
16 | 2 |
Product prescribing issue, Product use issue, |
||||
MOLNUPIRAVIR, |
||||
| 790 | 25044950 |
US |
||
Hallucination, Memory impairment, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 791 | 25045152 |
CA |
43 | 2 |
Alopecia, Amnesia, Anxiety, Asthenia, Asthma, Blood cholesterol increased, Breast cancer stage II, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gait disturbance, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hip arthroplasty, Hypertension, Hypoaesthesia, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Intentional product use issue, Irritable bowel syndrome, Knee arthroplasty, Lip dry, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Lupus vulgaris, Malaise, Migraine, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral venous disease, Product use issue, Psoriatic arthropathy, Pyrexia, Rheumatic fever, Rheumatoid arthritis, Road traffic accident, Sciatica, Sinusitis, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Weight decreased, Weight increased, Wound infection, Maternal exposure during pregnancy, Off label use, Contraindicated product administered, Medication error, Drug ineffective, Abdominal discomfort, Blister, Breast cancer stage III, Blepharospasm, Abdominal pain upper, Anti-cyclic citrullinated peptide antibody positive, Bursitis, Arthralgia, Arthropathy, C-reactive protein increased, Diarrhoea, Dizziness, Epilepsy, Gastrooesophageal reflux disease, General physical health deterioration, Hepatic enzyme increased, Peripheral swelling, Abdominal pain, Autoimmune disorder, Vomiting, Chest pain, Drug intolerance, Gait inability, Gastrointestinal disorder, Hypercholesterolaemia, Hypersensitivity, Ill-defined disorder, Joint range of motion decreased, Joint swelling, Liver disorder, Mobility decreased, Musculoskeletal stiffness, Oedema, Oedema peripheral, Rash, Pruritus, Respiratory tract infection, Rheumatoid factor positive, Swollen joint count increased, Synovitis, Product use in unapproved indication, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, APREMILAST, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ATOMOXETINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CALCIUM GLUCONATE, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, AZATHIOPRINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, BUPIVACAINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, PREGABALIN, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CANDESARTAN CILEXETIL, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LORAZEPAM, |
||||
| 792 | 25045217 |
CA |
43 | 2 |
Migraine, Off label use, Rheumatic fever, Swollen joint count increased, Taste disorder, Drug ineffective, Hypoaesthesia, Product quality issue, Malaise, Rheumatoid factor positive, Gastrooesophageal reflux disease, Treatment failure, Contraindicated product administered, Memory impairment, Blepharospasm, Decreased appetite, Epilepsy, Pain, Product use in unapproved indication, Asthenia, Blood cholesterol increased, Exposure during pregnancy, Hypertension, Liver function test increased, Liver injury, Maternal exposure during pregnancy, Mobility decreased, Muscular weakness, Musculoskeletal stiffness, Nausea, Oedema, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Prescribed overdose, Product use issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Seronegative arthritis, Sleep disorder, Spondylitis, Swelling, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Type 2 diabetes mellitus, Vomiting, Weight decreased, Wheezing, Wound, Wound infection, |
||||
HYDROXYCHLOROQUINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, RITUXIMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, TOCILIZUMAB, TOFACITINIB, VITAMIN C, TOFACITINIB, TOCILIZUMAB, PREDNISONE, APREMILAST, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, INFLIXIMAB, LEFLUNOMIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, OXYCODONE HYDROCHLORIDE, OXYCODONE, CELECOXIB, DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, HYDROCORTISONE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CAFFEINE CITRATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CALCIUM GLUCONATE, LISINOPRIL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RISEDRONATE SODIUM, AZATHIOPRINE, ERYTHROMYCIN, LISINOPRIL, MAGNESIUM, NAPROXEN, NAPROXEN SODIUM, RAMIPRIL, SULFASALAZINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, DESOXIMETASONE, ETANERCEPT, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOFACITINIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, TOFACITINIB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROCORTISONE, HYDROCORTISONE, FOLIC ACID, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, TOCILIZUMAB, TOCILIZUMAB, CELECOXIB, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, SULFASALAZINE, CELECOXIB, ABATACEPT, RITUXIMAB, RITUXIMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, FOLIC ACID, FOLIC ACID, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 793 | 25045305 |
US |
2 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 794 | 25045307 |
US |
2 | |
Product use issue, Intentional dose omission, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 795 | 25045364 |
US |
1 | |
Infection, Product use issue, |
||||
| 796 | 25045367 |
US |
||
Product use in unapproved indication, Product use issue, |
||||
DICLOFENAC SODIUM, |
||||
| 797 | 25045467 |
CA |
50 | 2 |
Arthralgia, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Autoimmune disorder, Blood cholesterol increased, Blister, C-reactive protein, Bursitis, C-reactive protein abnormal, Condition aggravated, Contraindicated product administered, Deep vein thrombosis postoperative, Discomfort, Drug ineffective, Lower limb fracture, Facet joint syndrome, Fibromyalgia, Gait inability, Folliculitis, Glossodynia, General physical health deterioration, Gastrointestinal disorder, Hip arthroplasty, Hand deformity, Ill-defined disorder, Drug intolerance, Hypoaesthesia, Irritable bowel syndrome, Impaired healing, Joint swelling, Joint range of motion decreased, Knee arthroplasty, Lung disorder, Liver disorder, Intentional product use issue, Mobility decreased, Muscle spasms, Muscle injury, Musculoskeletal stiffness, Musculoskeletal pain, Nasopharyngitis, Lower respiratory tract infection, Liver injury, Obesity, Osteoarthritis, Off label use, Night sweats, Pain, Injury, Lip dry, Paraesthesia, Peripheral venous disease, Pemphigus, Pericarditis, Psoriatic arthropathy, Product use issue, Rheumatoid arthritis, Rheumatic fever, Pregnancy, Sleep disorder due to general medical condition, hypersomnia type, Sinusitis, Sciatica, Rheumatoid factor positive, Swollen joint count, Road traffic accident, Product use in unapproved indication, Synovitis, Swollen joint count increased, Tender joint count, Type 2 diabetes mellitus, Treatment failure, Therapy non-responder, Therapeutic product effect decreased, Wound, Wheezing, Abdominal discomfort, Abdominal pain upper, Infection, Alopecia, Anxiety, Asthenia, Asthma, Chest pain, Dizziness, Confusional state, Contusion, Decreased appetite, Diarrhoea, Inflammation, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Fatigue, Headache, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Malaise, Maternal exposure during pregnancy, Oedema, Peripheral swelling, Nausea, Prescribed overdose, Pruritus, Pyrexia, Rash, Sleep disorder due to general medical condition, insomnia type, Infusion related reaction, Systemic lupus erythematosus, Urticaria, Vomiting, Weight increased, Swelling, Stomatitis, |
||||
NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MOXIFLOXACIN HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LORAZEPAM, CAFFEINE, CALCIUM, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM GLUCONATE, CALCIUM GLUCONATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETRIMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYALURONIDASE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SARILUMAB, SARILUMAB, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LISINOPRIL, LORAZEPAM, MAGNESIUM, MELOXICAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PIROXICAM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LANSOPRAZOLE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, VITAMIN C, DICLOFENAC SODIUM, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, LISINOPRIL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 798 | 25045514 |
DE |
4 | 1 |
Mucosal haemorrhage, Drug ineffective, Muscle abscess, Sepsis, Product use issue, Oral fungal infection, Off label use, |
||||
AMPHOTERICIN B, AMPHOTERICIN B, BASILIXIMAB, BASILIXIMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, VORICONAZOLE, VORICONAZOLE, HUMAN IMMUNOGLOBULIN G, LINEZOLID, MEROPENEM, |
||||
| 799 | 25045571 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 800 | 25045607 |
US |
34 | |
Product dose omission issue, Product use issue, |
||||
APIXABAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28